YQ:NASDAQ17 Education & Technology Group Inc. Analysis
Data as of 2026-08-01 - not real-time
$1.93
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading well below its short‑term and mid‑term moving averages, signaling a bearish technical stance. RSI sits in oversold territory while the MACD line remains under its signal, reinforcing downside momentum. Volume has been trending lower, and the recent price action reflects extremely high short‑term volatility despite a modest beta, suggesting limited correlation with broader market moves. The market sentiment gauge shows extreme greed, indicating that investors may be overly optimistic despite the underlying weakness.
Fundamentally, the company is posting negative earnings and operating margins, with no operating cash flow or free cash generation. Valuation multiples such as price‑to‑book and price‑to‑sales are low, but the negative earnings and severe historical drawdown raise serious concerns. The business operates in a heavily regulated Chinese education sector, exposing it to heightened regulatory and geographic risk, while its tiny market cap and thin trading volume amplify liquidity risk.
Fundamentally, the company is posting negative earnings and operating margins, with no operating cash flow or free cash generation. Valuation multiples such as price‑to‑book and price‑to‑sales are low, but the negative earnings and severe historical drawdown raise serious concerns. The business operates in a heavily regulated Chinese education sector, exposing it to heightened regulatory and geographic risk, while its tiny market cap and thin trading volume amplify liquidity risk.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- bearish technical indicators
- negative earnings and cash flow
- high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential for regulatory clarification
- low valuation multiples
- persistent liquidity constraints
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- ongoing regulatory headwinds in China
- structural profitability challenges
- limited upside given current market cap
Key Metrics & Analysis
Financial Health
Revenue Growth359.00%
Profit Margin-77.71%
P/E Ratio-0.7
ROE-44.79%
ROA-18.35%
Debt/Equity4.97
P/B Ratio0.5
Technical Analysis
TrendBearish
RSI39.7
Support$1.68
Resistance$2.54
MA 20$2.22
MA 50$2.29
MA 200$3.22
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.20
Volatility88.42%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.